The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Tailoring to RB: tumour suppressor status and therapeutic response
Open accessAbstract
The retinoblastoma tumour suppressor (RB) is a crucial regulator of cell-cycle progression that is invoked in response to a myriad of anti-mitogenic signals. It has been hypothesized that perturbations of the RB pathway confer a synonymous proliferative advantage to tumour cells; however, recent findings demonstrate context-specific outcomes associated with such lesions. Particularly, loss of RB function is associated with differential response to wide-ranging therapeutic agents. Thus, the status of this tumour suppressor may be particularly informative in directing treatment regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–220 of 220
Genetic Diversity of Hepatocellular Carcinomas and its Potential Impact on Targeted Therapies
Zucman‐Rossi, J., & Laurent‐Puig, P. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.8.997 · Cited by 38
Driving the Cell Cycle to Cancer
Malumbres, M., Hunt, S. L., Sotillo, R., Martín‐Broto, J., Odajima, J., Martín, A., Dubus, P. R., Ortega, S., & Barbacid, M. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0081-0_1 · Cited by 37
Fribourg, A. F., Knudsen, K. E., Strobeck, M. W., Lindhorst, C. M., & Knudsen, E. S. (2000) · PubMed · Cited by 37
Self-citationRole of the Retinoblastoma Tumor Suppressor in the Maintenance of Genome Integrity
Knudsen, E. S., Sexton, C. R., & Mayhew, C. N. (2006) · Current Molecular Medicine · doi:10.2174/1566524010606070749 · Cited by 37
Self-citationLoss of Rb overrides the requirement for ERK activity for cell proliferation
D’Abaco, G. M., Hooper, S., Paterson, H., & Marshall, C. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.00161 · Cited by 34
IncreasedRB1 abnormalities in human primary prostate cancer following combined androgen blockade
Mack, P. C., Chi, S.-G., Meyers, F. J., STEWART, S. L., White, R. D., & Gumerlock, P. H. (1998) · The Prostate · Cited by 33
Han, S., Park, K., Bae, B., Kim, K., Kim, H.-J., Kim, Y., & Kim, H.-Y. (2003) · Oncology Reports · doi:10.3892/or.10.1.141 · Cited by 31
Downregulation of the Retinoblastoma Gene Expression in the Progression of Malignant Melanoma
Korabiowska, M., Ruschenburg, I., Betke, H., Stachura, J., Schlott, T., Cardó, C. C., & Brinck, U. (2001) · Pathobiology · doi:10.1159/000064338 · Cited by 27
For Whom the Bell Tolls: Susceptibility to Common Adult Cancers in Retinoblastoma Survivors
Kaye, F. J., & Harbour, J. W. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh080 · Cited by 23
Is the Loss of pRb Essential for the Mouse Skin
Ruiz, S., Santos, M., & Paramio, J. M. (2006) · Cell Cycle · doi:10.4161/cc.5.6.2580 · Cited by 22
Chau, B. N., Pan, C. W., & Wang, J. Y. J. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000082 · Cited by 22
Agerbæk, M., Alsner, J., Marcussen, N., Lundbeck, F., & von der Maase, H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601063 · Cited by 22
Cole, S. L., & Tevethia, M. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8420-8432.2002 · Cited by 22
Varma, H., & Conrad, S. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203827 · Cited by 22
Tonks, I. D., Hacker, E., Irwin, N., Muller, H. K., Keith, P., Mould, A. W., Zournazi, A., Pavey, S. J., Hayward, N. K., Walker, G. J., et al. (2005) · Pigment Cell Research · doi:10.1111/j.1600-0749.2005.00245.x · Cited by 19
Predicting Risk of Breast Cancer Recurrence Using Gene-Expression Profiling
Ignatiadis, M., & Desmedt, C. (2006) · Pharmacogenomics · doi:10.2217/14622416.8.1.101 · Cited by 16
Murray, M. M., Terry, N. H. A., & Keyomarsi, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1809 · Cited by 15
Derenzini, M., Montanaro, L., Vici, M., Barbieri, S., Ceccarelli, C., Santini, D., Taffurelli, M., Martinelli, G., & Treré, D. (2007) · PubMed · doi:10.14670/hh-22.505 · Cited by 12
Analysis of RB Action in DNA Damage Checkpoint Response
Mayhew, C. N., Bosco, E. E., Solomon, D. A., Knudsen, E. S., & Angus, S. P. (2004) · Humana Press eBooks · doi:10.1385/1-59259-811-0:003 · Cited by 9
Self-citationMontanaro, L., Vici, M., Donati, G., Ceccarelli, C., Santini, D., Treré, D., & Derenzini, M. (2007) · PubMed · doi:10.14670/hh-22.769 · Cited by 5
Cited by
Liquid biopsy: monitoring cancer-genetics in the blood
Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.110 · Cited by 1,819
The history and future of targeting cyclin-dependent kinases in cancer therapy
Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767
Self-citationNon-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression
Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J., & Strasser, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.169 · Cited by 1,395
Cyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
Metadata
- Authors
- Knudsen, E. S., & Knudsen, K. E.
- Venue
- Nature Reviews Cancer
- Published
- 2008-08-07
- Volume
- 8
- Issue
- 9
- Pages
- 714-724
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2079941948
- Cited by
- 344
- References
- 220
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.